Preview

Rational Pharmacotherapy in Cardiology

Advanced search

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE

https://doi.org/10.20996/1819-6446-2010-6-6-832-836

Full Text:

Abstract

Aim. To compare the effects of fixed combinations of angiotensin converting enzyme inhibitor (enalapril) or angiotensin II receptor antagonist (losartan) with diuretic (hydrochlorothiazide, HCT) on the "office" blood pressure (BP) level in patients with arterial hypertension (HT) of 2-3 degrees.

Materials and methods. Patients (n=73; 34 men and 39 women; aged 50.5±5.8) with HT of 2-3 degrees were included in the study. Patients were randomized into 2 groups: patients of group 1 (n=34) received a fixed combination of enalapril with HCT; patients (n=39) of group 2 — a fixed combination of losartan with HCT. The study duration was 24 weeks. "Office" BP levels (Korotkov method) were evaluated.

Results. Combination of losartan with HCT shown more prominent effect on systolic BP (reduction from 176.1±2.77 to 122.3±1.54 mm Hg) in comparison with combination enalapril with HCT (reduction from 172.4±1.62 to 129.8±3.4 mm Hg) after 12 weeks of treatment (p<0.05). High frequency of target BP level achievement was observed in patients of groups 1 and 2 (83% and 86% respectively).

Conclusion. The fixed combination of enalapril or lozartan with HCT has high efficacy and can be recommended as initial therapy in patients with HT of 2-3 degree.

About the Authors

A. A. Kudryavtsev
I.M. Sechenov First Moscow State Medical University
Russian Federation
Ul. Trubetskaya 8/2, Moscow, 119991


A. S. Ryazanov
I.M. Sechenov First Moscow State Medical University
Russian Federation
Ul. Trubetskaya 8/2, Moscow, 119991


N. N. Eremenko
I.M. Sechenov First Moscow State Medical University
Russian Federation
Ul. Trubetskaya 8/2, Moscow, 119991


S. A. Kireev
Endocrinology Research Center
Russian Federation
Ul. Dmitry Ulyanov 11, Moscow, 117036


References

1. Hansson L., Zanchetti A., Carruthers S.G. et al. Effects of intensive blood-pressure lowering and lowdose aspirin in patients with hypertension: principalresults oftheHypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351(9118):1755-62.

2. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991;265(24):3255-64.

3. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288(23):2981-97.

4. Dahlöf B., Lindholm L.H., Hansson L. et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338(8778): 1281-5.

5. Pepine C.J., Handberg-Thurmond E., Marks P. et al. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an internet – based randomized trial in coronary artery disease patients with hypertension. JACC 1998; 32(5): 1228–37.

6. Dahlöf B, Devereux RB, Kjeldsen SE et al. for the LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359(9311):995-1003.

7. National guidelines for diagnosis and treatment of hypertension. Kardiovaskuljarnaja terapija i profilaktika 2008; 7(6) Prilozhenie 2; 1-32. Russian (Национальные рекомендации по диагностике и лечению артериальной гипертонии. Кардиоваскулярная терапия и профилактика 2008; 7(6)Приложение 2; 1-32).

8. Leonova M.V., Belousov D.Ju., Analysis Group study PIFAGOR. The first Russian Pharmacoepidemiological study of hypertension. Kachestvennaja klinicheskaja praktika 2002; 3: 47-53. Russian (Леонова М.В., Белоусов Д.Ю., аналитическая группа исследования ПИФАГОР. Первое Российское фармакоэпидемиологическое исследование артериальной гипертонии. Качественная клиническая практика 2002; 3: 47-53).

9. Ostroumova O.D., Golovina O.V. When should I start treatment of hypertension with fixed combinations? New trends. Consilium Medicum 2005; 7(1): 28-31. Russian (Остроумова О.Д., Головина О.В. Когда необходимо начинать лечение артериальной гипертонии с фиксированных комбинаций? Новые тенденции. Consilium Medicum 2005; 7(1): 28-31).

10. Afaunov R.H.,KrutikovA.N.,Kirienkov I.S. et al.Antihypertensive activity and effect on cardiac remodeling of long-term therapy by Renitec / Co-Renitec according to the study of RU-003. Consilium Medicum 2002; 8(5):173-176. Russian (Афаунов Р.Х., Крутиков А.Н., Кириенков И.С., и др. Антигипертензивная активность и влияние на ремоделирование сердца длительной терапии ренитеком / коренитеком по данным исследования RU-003. Consilium Medicum 2002; 8(5):173-176).

11. Chazova I.E., Ratova L.G. Combined treatment of arterial hypertension (results of the international program CLIP-ACCORD). Ter Arkh 2009;81(5):60-4. Russian (Чазова И.Е., Ратова Л.Г. Комбинированная терапия артериальной гипертонии (итоги международной программы КЛИП-АККОРД). Тер архив 2009;81(5): 60-63).

12. Ratova L.G.,AtaullahanovaD.M., Tolpygina S.N.,Chazova I.E.Comparative assessment of antihypertensive and cardioprotective effects of losartan and its fixed combination with hydrochlorothiazide. Consilium Medicum 2004; 6(2): 26-32. Russian (Ратова Л.Г., Атауллаханова Д.М., Толпыгина С.Н., Чазова И.Е. Сравнительная оценка антигипертензивного и кардиопротективного эффектов лозартана и его фиксированной комбинации с гидрохлортиазидом. Consilium Medicum 2004; 6(2): 26-32).

13. Chihladze N.M., Sivakova O.A., Samedova H.F. et al. Comparative analysis of losatan and enalapril antihypertensive efficacy (ELLA trial). Rational Pharmacother. Card. 2008;1:44-48. Russian (Чихлад- зе Н.М., Сивакова О.А., Самедова Х.Ф. и др. Сравнительный анализ антигипертензивной эффективности лозартана и эналаприла (исследование ЭЛЛА). РФК 2008; 1: 44-48).

14. Papademetriou V., Devereux R.B., Narayan P. et al. Similar effects of isolated systolic hypertension on left ventricular geometry and function: the LIFE study. Am J Hypertens 2001; 14(8 Pt 1):768-74.


For citation:


Kudryavtsev A.A., Ryazanov A.S., Eremenko N.N., Kireev S.A. ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE. Rational Pharmacotherapy in Cardiology. 2010;6(6):832-836. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-6-832-836

Views: 353


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)